All Activity

President Donald Trump’s historic move to direct the reclassification of marijuana on Thursday has elicited a wave of positive feedback from top lawmakers, state officials, advocates and industry stakeholders—reflecting the uniquely bipartisan way cannabis reform has bridge political divides during an especially divisive time. While several Democratic lawmakers have made clear that simply moving cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) does not go far enough, even some of Trump’s sharpest critics have generally agreed that the executive order directing the incremental reform is a step in the right direction. The order directs the attorney general to complete a rescheduling process that was initiated under the Biden administration. The reclassification wouldn’t legalize marijuana, but it would loosen research restrictions, allow cannabis businesses to take federal tax deductions and symbolically recognize that the plant holds medical value—breaking from the federal government’s decades-long position that it is therapeutically ineffective with a high abuse potential. The order also has implications for the hemp market, with a call to reevaluate how the crop is defined under a newly enacted spending bill that stakeholders say would ultimately eradicate the industry by banning most consumable cannabinoid products. Here’s how people are reacting to the rescheduling news: Senate Minority Leader Chuck Schumer (D-NY) “Though a step in the right direction, more must be done to decriminalize cannabis, ease overly restrictive banking regulations that stall industry progress in states where it is legal, and rectify the harms done by the War on Drugs. I remain committed to the SAFER Banking Act and the Cannabis Administration and Opportunity Act to accomplish these goals.” This is a step in the right direction—but more work must be done to decriminalize cannabis, ease overly restrictive banking regulations that stall industry progress in states where it is legal, and rectify the harms done by the War on Drugs. I remain committed to the SAFER… https://t.co/8vdDvD88h1 — Chuck Schumer (@SenSchumer) December 18, 2025 Sen. Rand Paul (R-KY) The federal war on drugs has failed for decades because Washington insists on controlling what it cannot fix. President Trump recognizes that reality, and I applaud him for ignoring the tired “reefer madness” rhetoric and moving forward with rescheduling.@POTUS https://t.co/79sPbSgQb3 — Senator Rand Paul (@SenRandPaul) December 18, 2025 Rep. Dave Joyce (R-OH) Proud to see @POTUS deliver on his commitment to the American people with the EO to reschedule cannabis. This is a win for patients—especially seniors & veterans—who deserve clear info, access to care, and choice with their doctors. This common-sense action ends blocked… https://t.co/rnNqrSejiA — Dave Joyce (@RepDaveJoyce) December 18, 2025 Rep. Dina Titus (D-NV) Okay. Now let’s de-schedule cannabis entirely. https://t.co/aqLczekQHF — Dina Titus (@repdinatitus) December 18, 2025 Rep. Greg Steube (R-FL) For years, I’ve been pushing common-sense legislation to reschedule marijuana from a Schedule 1 to a Schedule 3 substance. (There’s no logical reason why it should have been treated the same as drugs like heroin or LSD for the last 50+ years!) Rescheduling marijuana is a… pic.twitter.com/3IKt53Phef — Congressman Greg Steube (@RepGregSteube) December 18, 2025 Former Rep. Earl Blumenauer (D-OR) “I am delighted that at Long last there will be some federal movement on rescheduling… This is not everything we want, but it is a huge step forward, dealing with banking, taxation and the mindset for reform. I have long felt that this could be the break, the crack in the dam that allows the waters of reform to rush out. It is frustrating that is taken this long, but it is hugely significant and should not be underestimated about leading to a chain of events for more meaningful reforms.” Colorado Gov. Jared Polis (D) “To be blunt, it’s far past time for the federal government to catch up to Colorado and many other states and get rid of arcane federal policies on cannabis that aren’t based in reality and hurt Colorado small businesses and public safety. I thank the President and am pleased that they are finally taking this step to begin the process to reschedule. For years Colorado has been a national leader in smart and safe cannabis policy that has virtually eliminated illegal markets, ensured safe use, and generated over a billion dollars for education. Colorado’s cannabis industry is the gold standard ensuring that products are safe and regulated. It’s good to see the federal government finally following suit, but it’s frustrating it’s taken this long and there is much more to do for a full descheduling.” Nevada Cannabis Compliance Board “As President Trump signs an executive order reclassifying cannabis, the Nevada Cannabis Compliance Board is prepared to navigate the changes ahead alongside industry and State lawmakers. The CCB will continue to regulate licensing matters and oversee compliance measures from seed-to-sale, upholding public health and safety.” Michigan Cannabis Regulatory Agency Executive Director Brian Hanna “While we are still assessing the details of the order, this development has the potential to move the federal marijuana policy debate forward after years of advocacy by patients, businesses, and states across the country. Rescheduling marijuana carries important implications – but also clear limitations – for state-regulated markets. That distinction is critical for policymakers, media, and the public to understand as this process continues… We look forward to completing our review of the executive order and continuing to work with our federal partners to ensure that any change in classification is accompanied by clear guidance and thoughtful implementation that meaningfully addresses long-standing barriers – particularly in banking, research, social equity, and taxation – while preserving the authority, safety, and integrity of state-regulated systems like Michigan’s.” Pennsylvania State Sen. Sharif Street (D) For more than a decade, I’ve led efforts in Pennsylvania to modernize our cannabis laws because prohibition has failed—especially for Black and Brown communities who have borne the brunt of criminalization. (2/4) — Senator Sharif Street (@SenSharifStreet) December 18, 2025 NORML Deputy Director Paul Armentano “The Administration’s order calling to remove the cannabis plant from its Schedule I classification validates the experiences of tens of millions of Americans, as well as those of tens of thousands of physicians, who have long recognized that cannabis possesses legitimate medical utility. It wasn’t long ago that federal officials were threatening to seize doctors’ medical licenses just for discussing medical cannabis with their patients. This directive certainly marks a long overdue change in direction. But while such a move potentially provides some benefits to patients, and veterans especially, it still falls well short of the changes necessary to bring federal marijuana policy into the 21st century. Specifically, rescheduling fails to harmonize federal marijuana policy with the cannabis laws of most states, particularly the 24 states that have legalized its use and sale to adults — thereby leaving those who produce, dispense, possess, or use marijuana in compliance with state laws in jeopardy of federal prosecution. In order to rectify this state/federal conflict, and in order to provide state governments with the explicit authority to establish their own cannabis regulatory policies — like they already possess with respect to alcohol — cannabis must be removed from the Controlled Substances Act altogether. Doing so would affirm America’s longstanding principles of federalism and appeal to Americans’ deep-rooted desires to be free from undue government intrusion into their daily lives. Nevertheless, as a first step forward, this federal policy change dramatically shifts the political debate surrounding cannabis. Specifically, it delegitimizes many of the tropes historically exploited by opponents of marijuana policy reform. Claims that cannabis poses unique harms to health, or that it’s not useful for treating chronic pain and other ailments, have now been rejected by the very federal agencies that formerly perpetuated them. Going forward, these specious allegations should be absent from any serious conversations surrounding legalizing and regulating cannabis. Finally, he added: “It is anticipated that reclassification will also provide tax fairness to state-licensed businesses — allowing them, for the first time, to take traditional tax deductions. This change levels the playing field and lowers these entities’ costs of doing business. This change also likely benefits cannabis consumers by resulting in lower overall prices for state-licensed retail products, further incentivizing them to abandon the underground market.” Marijuana Policy Project Executive Director Adam J. Smith “While MPP welcomes the President’s proposal to move cannabis from Schedule I to Schedule III, neither the plant itself nor its naturally occurring component cannabinoids belong on the schedule at all. We hope this move to Schedule III truly does open up medical research, that it inspires states to guarantee access to safe, regulated cannabinoids for patients who desperately need them, and that the regulated industry might finally be treated more fairly under the federal tax code. But a move to Schedule III does nothing to end hundreds of thousands of possession arrests each year, nor does it do anything to fix the untenable, ongoing disconnect between federal prohibition and the regulated state markets under which more than half of American adults live. We are pleased that the President is taking this important step, but it is only a step. It is long past time to deschedule cannabis entirely and end nearly a century of failed prohibition.” The Weldon Project’s Weldon Angelos, who received a marijuana pardon from Trump “President Trump’s decision to reschedule cannabis is a major first step toward ending prohibition, and while more work remains, including clemency for those still incarcerated for cannabis, this is a moment worth recognizing and celebrating.” Last Prisoner Project Director of Strategic Initiatives Jason Ortiz “President Trump’s decision to reschedule cannabis is a historic step that reflects the will of the American people. However, moving cannabis to a lower schedule does nothing for the tens of thousands of Americans still locked behind bars for actions that are now legal in most of the country. Thankfully, President Trump has demonstrated he is willing to act boldly to correct outdated policies. By pairing rescheduling with clemency for people incarcerated for cannabis, he can cement his legacy as the leader who has done more for cannabis justice than any other president in American history.” Cannabis Regulators of Color Coalition Board Director of Policy Cat Packer “The American people overwhelmingly support legalization and an end to federal marijuana criminalization. Rescheduling marijuana continues federal criminalization, regardless of state law, and falls far short of the reforms our communities need and deserve.” American Legion National Commander Dan K. Wiley “This is a really important executive order, and The American Legion has long advocated for this change. Cannabis being classified schedule 1 blocks large-scale, randomized clinical trials examining cannabis’ impact on PTSD, TBI, sleep disruption, anxiety, depression, and chronic pain…conditions strongly associated with veteran suicide. Reclassification is not legalization and does not mandate use. It simply removes federal barriers to research and informed decision-making. It promotes transparency, clinician oversight, informed consent, and honest patient-provider discussions – reducing unsafe self-medication. Supporting reclassification demonstrates the Legion’s commitment to science, oversight, and saving lives through evidence-based public health policy.” National Association of Criminal Defense Lawyers President Andrew Birrell “Rescheduling cannabis is an incremental, imperfect improvement. While moving this drug from the Schedule I shadow is a small step off the cliff of cruel prohibition, it’s not the lifeline for justice we desperately need. A reclassified schedule still leaves a web of harmful criminal penalties intact, meaning the War on Drugs will continue to ensnare Americans in a failed punishment scheme. The current federal approach has demonstrably failed to enhance public safety, instead diverting taxpayer dollars to enforcement while maintaining needlessly harsh sentences. This over-criminalization has created devastating collateral consequences—the loss of access to housing, employment, and education—for individuals and families. Crucially, the enforcement of federal cannabis law has been defined by profound racial disparities. Black Americans are nearly four times more likely to be arrested for marijuana possession than white Americans, despite comparable usage rates. Even with declining federal prosecutions for possession and trafficking, the average sentence for federal marijuana felonies remains a staggering 37 months, with 70% of those offenders having little or no criminal history.” UFCW International President Milton Jones “The Administration’s plan to reclassify cannabis amounts to a tax giveaway for cannabis business owners without any protections for the workers who power this industry. Similar to the Biden Administration’s plan, this effort risks creating an industry that reinforces the inequities present throughout our economy. Hundreds of thousands of cannabis workers will still face the same challenges that they do now, including the lack of access to proper job training and health and safety protections. Reclassifying cannabis from a Schedule I to Schedule III drug ignores the needs of workers and wastes the chance to finally deliver justice for the families impacted by the War on Drugs. Cannabis must be federally decriminalized, with a regulatory framework to ensure that cannabis workers, from seed to sale, have the health, safety, and labor protections they deserve.” National Cannabis Industry Association (NCIA) Director of Government Relations Michelle Rutter Friberg “Medical professionals, patients, and millions of Americans have long understood that cannabis has accepted medical use and does not belong in the same category as the most dangerous controlled substances. By taking this step, the Administration is recognizing the realities of today’s regulated markets and the work states have done to responsibly oversee them… This is meaningful progress, but it cannot be the final word. NCIA urges lawmakers to build on today’s decision by establishing a framework that respects states’ rights, supports responsible operators, and provides  clear federal enforcement guidelines in order to provide certainty to the thousands of businesses operating openly and in compliance with state law. NCIA will continue working to ensure that this industry can thrive under policies that are fair, consistent, and reflective of modern realities.” Dutchie Chairman and CEO Tim Barash, who also serves as co-chair of the Coalition for Cannabis Scheduling Reform “Moving cannabis to Schedule III represents a fundamental shift in how the federal government and society at large view the plant, transforming the way the cannabis industry operates. This change will empower the 425,000 people working in the US cannabis industry and bring in new talent, capital, and awareness to an industry that has a positive impact on millions of people’s lives… One of the most immediate impacts of rescheduling is the end of the 280E tax penalty, removing a long-standing barrier to growth. This change will also bring in large institutions and services across the business and banking world, allowing this major US industry to have the same support as the rest of our economy. When federal policy catches up to reality, it changes how consumers, families, and patients think about cannabis. That matters just as much as the business impact.” American Trade Association for Cannabis & Hemp (ATACH) President Michael Bronstein “Today’s decision to move cannabis to Schedule III marks the most significant federal shift in cannabis policy in over 50 years. After decades of outdated policy, the federal government has finally acknowledged what we as a movement have said for a generation: that marijuana can be medicine. It opens doors to expanded medical research and helps reduce the stigma and provide for better patient outcomes. This change also brings long overdue equal tax treatment by lifting draconian tax penalties on state-legal businesses, and allowing reinvestment in local jobs and communities. Today is a celebration, but our work is not done and we will build on this momentum to establish a comprehensive regulatory framework to fully end prohibition in America.” Cresco Labs CEO Charlie Bachtell, who also serves as chair of U.S. Cannabis Roundtable “The U.S. Cannabis Roundtable commends President Trump and the Trump Administration for moving to reclassify cannabis as a Schedule III drug. Once completed, this shift will mark a dramatic break with the failed policies of the past. Cannabis has widely accepted medical uses and low abuse potential. It never belonged at Schedule I. After more than five decades, this untenable status quo is finally coming to an end.” Trulieve Chief Executive Officer Kim Rivers “This bold and historic direction from President Trump represents long overdue change and a major milestone in cannabis reform. Trulieve is grateful for the decisive action taken by the Administration that acknowledges the medical benefits of cannabis, supports licensed and regulated operators, and allows law enforcement agencies to prosecute bad actors. We are committed to supporting the Administration throughout this process.” Some days make all of the hard work worth it. Today is one of those days! Thank you @POTUS for making history by rescheduling marijuana to Schedule III. It has been an honor to work with you to get this done for the millions of Americans who use medical cannabis and who deserve… pic.twitter.com/TynVYAsZgL — Kim Rivers (@rivers_kim) December 18, 2025 Scotts Miracle-Gro Company CEO Jim Hagedorn “With 39 states already legalizing cannabis in some form, rescheduling to a lower level drug on the federal level has been long overdue. President Trump deserves credit and praise for taking this bold action, as it reflects the will of the people and sets the stage for much-needed research into the medical use of cannabis. Just as importantly, this will help deliver a blow to the illicit cannabis market by strengthening the financial viability of the legal and regulated industry that employs over 425,000 people and contributes $100 billion to the economy.” Curaleaf Chairman and CEO Boris Jordan “Curaleaf thanks President Trump for acting on his commitment to move forward with cannabis reclassification and we express our deep gratitude to him for this bold move. Moving the plant from Schedule I to Schedule III acknowledges what has been known for thousands of years, that the cannabis plant has medicinal properties. This policy shift by the United States government sets a precedent for how cannabis should be viewed globally and we eagerly await Attorney General Pam Bondi’s prompt execution of President Trump’s order.” Brian Vicente, founding partner at Vicente LLP “This monumental change will have a massive, positive effect on thousands of state-legal cannabis businesses around the country. One dominating inequity cannabis businesses face is the inability to deduct regular business expenses, since they sell a Schedule I substance. Rescheduling releases cannabis businesses from the crippling tax burden they have been shackled with and allow these businesses to grow and prosper. We work with hundreds of licensed cannabis businesses, and the ability to deduct ordinary operating costs under the Schedule III proposal is a game-changer for them.” Cato Institute Senior Fellow Jeffrey Singer “This is a positive step in the right direction, but it won’t significantly change things for people who use cannabis medically or recreationally in states where it is legal. It might make it easier to conduct medical research on cannabis, and it could help state-licensed cannabis retailers cover business costs, but overall, it just rearranges the landscape of cannabis prohibition.” Smart Approaches To Marijuana (SAM) President Kevin Sabet “This rule, if finalized, will herald a public health disaster. It’s a full betrayal of the President’s promise to keep all Americans safe and healthy. This is a giant gift to Big Marijuana and its pushers who are now more incentivized to target children with their highly addictive products. Thankfully, this decision does not legalize marijuana, but it gifts the industry with more than $2 billion in tax write-offs at a time when their advertising is inflicting carnage on America’s families. In reality, this is a pyrrhic victory for the industry. They have failed in their attempt to legalize their products, banking, and they were dealt a huge blow with the new law outlawing Delta-8 and other synthetic pot products. In addition, they are facing increased pressure in legalized states, with several now considering a rollback of such policies. The implications for marijuana products remain unclear, since now the Food and Drug Administration (FDA) will have enforcement jurisdiction over them in a way only the Drug Enforcement Administration currently does.” U.S. Hemp Roundtable General Counsel Jonathan Miller “The U.S. hemp industry is deeply grateful to President Trump for issuing his strong pro-hemp Executive Order today. While the headlines of the announcement will focus on marijuana rescheduling – which is a positive in itself, for any cannabis reform benefits the entire plant – we are especially pleased to see the provisions that direct the White House staff and urge Congress to ensure access to hemp-derived, full-spectrum CBD products, a lifeblood of the industry. We are also thrilled to see the development of a model that would allow a number of Medicare beneficiaries to receive CBD under doctor recommendation at no cost. We consider this Executive Order to be a direct rebuke to the hemp ban that was malignly attached to legislation that reopened government. This also gives strong impetus to efforts to extend the ban’s moratorium an additional 18 months to allow proper time for Congress and the Trump Administration to develop the regulatory framework that ensures the safe provision of hemp products while cracking down on the bad actors peddling the unsafe products that the Executive Order calls out. We look forward to working with the President, his staff, HHS, and Congress in the coming months to ensure the bipartisan vision of a safe, legal, and regulated hemp extract industry.” American Trucking Associations’ Vice President of Safety Policy Brenna Lyles “While we do not hold a formal position on marijuana legalization or deregulation, we are concerned about the safety risks of rescheduling marijuana without explicit safeguards to preserve the testing authority and technical requirements that apply to DOT-regulated, safety-sensitive workers. A safe driver is a qualified driver. And a qualified driver is drug- and alcohol-free. Motor carriers must retain reliable, enforceable tools to ensure they are not putting unqualified drivers behind the wheel. Without clear measures to ensure DOT’s drug- and alcohol-testing program retains—and is equipped to execute—marijuana testing authority, such a federal policy shift could have serious consequences for highway safety and the integrity of the national transportation network. This risk is exacerbated by the fact that there is currently no proven, widely accepted standard to determine marijuana impairment at roadside or before a driver begins operating a vehicle, making it far more difficult to prevent impaired driving. The stakes are not theoretical. Marijuana accounts for nearly 60 percent of all positive drug tests among commercial drivers subject to DOT testing requirements. We appreciate the Department of Transportation’s ongoing commitment to highway safety and its work to strengthen driver qualification and enforcement standards. We urge DOT to proactively coordinate with HHS, DOJ, and Congress to ensure that any federal policy shift preserves a holistic approach to safety, one that maintains the authority, tools, and technical capacity necessary to keep impaired and unqualified drivers off our roads.” Boxer Mike Tyson Thank you @POTUS @realDonaldTrump for rescheduling cannabis. This decision reflects listening to people across the country and taking a practical step toward modernizing outdated policies. It supports American workers, families, and businesses, and allows over 500,000 existing… — Mike Tyson (@MikeTyson) December 18, 2025 Former NFL Player Ricky Williams, who is a co-founder of Project Champion “For over 50 years, cannabis has been wrongly classified alongside the most dangerous substances in America. This Executive Order represents a long-overdue recognition that cannabis has legitimate medical value and that patients deserve policies grounded in science, compassion, and reality.” The post Lawmakers, State Officials, Advocates And Industry React To Trump’s Marijuana Rescheduling Order appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump on Thursday dismissed the concerns of GOP lawmakers who oppose his freshly signed executive order to reschedule marijuana, pointing out that an overwhelming majority of Americans support the reform and that cannabis can help people—including his personal friends—who are suffering from serious health issues. At a signing ceremony, the president issued an order directing the attorney general to “complete” the process of moving marijuana from Schedule I to Schedule III in the “most expeditious manner,” while also announcing plans to make full-spectrum CBD products available to patients through their health providers that could be covered by Medicare. After signing the order, Trump was asked about GOP opposition to the reclassification decision, which included a last-ditch push from groups of House and Senate Republicans to dissuade him from moving forward. The president said he’d prefer to have the medical professionals in attendance at the event take that question, but emphasized that polling has found that four in five Americans are in favor of rescheduling cannabis. The reform wouldn’t legalize marijuana, but it would ease research restrictions and let marijuana businesses take federal tax deductions available to other traditional industries. “I can only tell you that when you see polls [showing] 82 percent of the people want this” and have friends who are “really, really sick” and found relief with cannabis, the policy makes sense, Trump said. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), also responded to the reporter’s question about GOP lawmaker opposition, stressing that strictly prohibiting marijuana as a Schedule I drug for decades “hasn’t protected neither the adolescents nor the adults.” “This is not legalizing it. It’s making it easier to do research,” Volkow, who has long criticized keeping cannabis in Schedule I due to research limitations, said. Meanwhile, amid the heightened rumors that the Trump administration would be moving forward on marijuana rescheduling, multiple top congressional Democrats made the case that the reform would not go far enough—including one senator who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. The post Trump Dismisses GOP Lawmakers’ Opposition To His Marijuana Rescheduling Action, Pointing To Polling And Medical Benefits appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Marijuana will be federally rescheduled under an executive order signed by President Donald Trump on Thursday. The directive also aims to address federal hemp laws to promote access to full-spectrum CBD that could be covered under federal health insurance plans. Months after Trump said a decision on the cannabis reform proposal was imminent, the president issued the directive for agencies to begin moving forward with the plan to transfer cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). “We have people begging for me to do this, people that are in great pain for decades,” Trump said. “This action has been requested by American patients suffering from extreme pain, incurable diseases, aggressive cancers, seizure disorders, neurological problems and more—including numerous veterans with service-related injuries and older Americans who live with chronic medical problems that severely degrade their quality of life.” The president emphasized that his order “doesn’t legalize marijuana in any way, shape or form, and in no way sanctions its use as a recreational drug.” This marks one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Rescheduling will not federally legalize cannabis. But the policy change will allow state-licensed marijuana businesses to take federal tax deductions they’ve been deprived under an Internal Revenue Service (IRS) code known as 280E. It will also remove certain research barriers applied to Schedule I drugs. The change may also spur additional states to modernize their own policies on cannabis, as some lawmakers have cited the federal government’s restrictive classification of marijuana as a reason they have been uncomfortable with enacting legalization or at least allowing medical use. In addition to directing the attorney general to “take all necessary steps to complete the rulemaking process related to rescheduling marijuana to Schedule III of the CSA in the most expeditious manner in accordance with Federal law,” Trump’s executive order also urges Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients. If lawmakers do so, it could mitigate some concerns in the sector about a recent spending bill the president signed with provisions that would broadly ban consumable hemp products. A further redefinition of hemp would be part of a novel proposal to allow Medicare recipients to access non-intoxicating CBD that’d be covered under the federal health care plan. To effectuate that, the Centers for Medicare & Medicaid Services (CMS) will also be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” a White House official said during a briefing earlier on Thursday that Marijuana Moment first reported leaked details from ahead of the signing event. The CBD effort is a policy Trump seemed to endorse over the summer when he shared a video calling for that specific reform while promoting the health benefits of cannabidiol, particularly for seniors. During the signing ceremony on Thursday, Trump noted strong public support for marijuana reform and said he has received numerous phone calls in support of rescheduling. “I don’t think I received any calls on the other side of it,” he said. “I promised to be the president of common sense, and that is exactly what we’re doing,” Trump said. “This is really something having to do with common sense, and it’s something having to do with the fact that so many people that I respect asked me to do—people that are having problems, big problems, that are having big problems with illness, with cancer in particular.” President Donald J. Trump signs an Executive Order rescheduling marijuana from Schedule I to Schedule III — recognizing legitimate medical uses and expanding medical marijuana and cannabidiol research to better support patients and doctors. pic.twitter.com/7NpPaLbNTl — The White House (@WhiteHouse) December 18, 2025 Trump endorsed rescheduling—as well as industry banking access and a Florida adult-use legalization initiative—on the campaign trail last year. The president had been largely silent on the issue since taking office during his second term, until a briefing in August where in response to a reporter’s question he announced the administration would decide on rescheduling within weeks. By moving forward with the plan, Trump is completing a process initiated under the Biden administration. That involved a scientific review by the U.S. Department of Health and Human Services (HHS)—which concluded that Schedule III is a more appropriate category for marijuana—as well as the Drug Enforcement Administration (DEA). HHS Secretary Robert F. Kennedy Jr. said on Thursday that the question of cannabis “has divided our country for many, many years, and there are valid claims on both sides.” “On one side, patients and physicians attest that cannabinoids and THC can be have miraculous effects on chronic pain, on epilepsy, on PTSD, on chemotherapy induced nausea,” he said. “On the other side, there are valid claims about the negative impacts, about addiction, about psychosis, about adverse public health impacts and impacts, particularly on young people.” Recent news reports revealed that Trump was planning to issue the executive order directing federal agencies to move ahead with cannabis rescheduling following a meeting with marijuana industry executives, Kennedy and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump reportedly phoned House Speaker Mike Johnson (R-LA), who expressed his opposition to rescheduling cannabis. The rescheduling announcement comes weeks after the president signed a key spending bill that would effectively ban most consumable hemp products, drawing criticism from stakeholders in the hemp industry who argue the policy change would eradicate the market. Meanwhile, amid the heightened rumors that the Trump administration would be moving forward on marijuana rescheduling, multiple top congressional Democrats made the case that the reform would not go far enough—including one senator who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. Dozens of Republican members of Congress have urged Trump not to reschedule marijuana, arguing that it would harm public health and safety. A White House fact sheet on the president’s order stresses that rescheduling “corrects the Federal government’s long delay in recognizing the medical use of marijuana and will vastly improve research on safety and efficacy.” “The lack of appropriate research on medical marijuana and consequent lack of FDA approval leaves American patients and doctors without adequate guidance on appropriate prescribing and utilization, especially as just over half of older Americans using marijuana have discussed the usage with their healthcare provider,” it says. “Schedule III status will allow research studies to incorporate real-world evidence and models that can assess the health outcomes of medical marijuana and legal CBD products while focusing on long-term health effects in vulnerable populations like adolescents and young adults.” The post Trump Signs Executive Order To Reclassify Marijuana By Removing It From Schedule I appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

President Donald Trump will be signing an executive order on Thursday that will direct the attorney to “expedite” and “complete” the marijuana rescheduling process, throw a lifeline to the hemp industry, allow doctors to prescribe CBD products that would be eligible for Medicare coverage and more, a White House official told reporters at a readout ahead of the signing event. Marijuana Moment wasn’t invited to attend the background briefing, but obtained the transcript of the conversation. Many details are consistent with reporting about the plan to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA), but the discussion revealed additional information about the order and how the administration is framing the reform. The official started by emphasizing that the “common sense” administrative action is “focused on increasing medical research for medical marijuana and CBD” to “better inform patients and doctors.” That means expediting the finalization of a rule to reschedule marijuana, they said. The move wouldn’t legalize cannabis, but it would help promote research while also letting marijuana businesses take federal tax deductions they’ve been barred from under an Internal Revenue Service (IRS) code known as 280E. Here are new details about Trump’s executive order on cannabis: Direct the attorney general to expedite the completion of the process of rescheduling marijuana to Schedule III of the CSA. Direct top White House staff to work with Congress to give patients access to full-spectrum CBD products, “while still restricting the sale and access to products that cause serious and potentially life threatening health risks.” Urge Congress to examine updating the definition of hemp to ensure that full-spectrum CBD is accessible to patients—a policy change that could mitigate some concerns in the sector about a recent spending bill Trump signed with provisions that would broadly ban consumable hemp products. Direct the U.S. Department of Health and Human Services (HHS) to “develop research methods and models, to utilize real world evidence [and] to improve access to hemp-derived CBD products in accordance with federal law” while informing “standards of care.” Separate from Trump’s order, Mehmet Oz, administrator for the Centers for Medicare & Medicaid Services (CMS), will also be announcing “a model that will allow a number of CMS beneficiaries to benefit from receiving CBD under doctor recommendation at no cost,” the White House official said. “This is hemp-derived CBD products that would be eligible to receive CBD at no cost under a doctor’s recommendation,” they said. “The product must meet local and state quality and safety laws, come from a legally compliant source and be tested by a third party for CBD levels and contaminants.” While there’s been reporting that Trump’s order would include a directive to Congress to advance a cannabis banking reform bill and possible clemency action, those two details were not mentioned at the media briefing. But the order itself hasn’t been released yet, so it remains to be seen if those work into the action. “The president’s intent…is to remove barriers to research,” the White House staffer said. “The president has heard from so many people who have talked about the potential benefits of medical marijuana and CBD, but he’s also heard from patients and and from doctors that there’s not enough research to inform medical guidelines that many patients are using these products without talking to their doctor about them.” “As a Schedule I substance, marijuana has been defined historically as having no currently accepted medical use, a high abuse potential and a lack of accepted safety for use in their medical supervision,” they said, noting that federal agencies recommended rescheduling cannabis during the Biden administration following a “lengthy” scientific review that determined the plant and its constituents do, in fact, hold medical value. “The president’s directive to the attorney general is to complete that process,” they said, adding that seniors and people with chronic pain in particular may benefit from cannabis as an alternative therapy option. On hemp products, the White House staffer noted that the spending bill Trump recently signed redefined legal hemp products to have a legal limit of 0.4 milligrams per container. “The president’s directive is asking Congress to…potentially update that definition, so that full-spectrum CBD products would still be available.” National Institute on Drug Abuse Director Nora Volkow also spoke on the call, emphasizing how rescheduling will boost research on cannabis. “It’s important…because many Americans are using cannabis for medical purposes, and yet, for the most part, the evidence is not there in terms of not just what are the benefits, but also how to optimally give it to those individuals for which the condition does respond to cannabis,” she said. “I think it’s important to recognize that it is very likely that cannabis has potential therapeutic applications, but we also know very clearly that cannabis can be addictive,” Volkow said. “Thus, it’s crucial that we do research also in order to be able to optimally develop treatments that can help people addicted to cannabis, while at the same time pursuing the research that will enable us to understand under what conditions cannabis may have a therapeutic purpose for and how to minimize the risk.” The post Trump’s Marijuana Executive Order Details Leaked Ahead Of Announcement, Including CBD And Hemp Provisions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Republican congressional lawmakers are making a last-ditch attempt to convince President Donald Trump not to follow through with reported plans to reschedule marijuana—with a pair of letters from House and Senate members who say the move would be a mistake. The House letter says rescheduling cannabis would “send the wrong message to America’s children, enable drug cartels, and make our roads more dangerous.” The representatives—led by Reps. Pete Sessions (R-TX) and Andy Harris (R-TX)—said cannabis is a “harmful drug that is worsening our nation’s addiction crisis.” The Senate letter, organized by Sen. Ted Budd (R-NC), told Trump that moving marijuana to Schedule III would “undermine your strong efforts to Make America Great Again and to usher in America’s next economic Golden Age.” The House members’ letter attempts to appeal to Trump by characterizing the reform as a “Biden Administration rescheduling decision,” saying that the former president’s team tried to “expand the use of an addictive drug for partisan gain.” “Rescheduling marijuana will not make America great,” the lawmakers wrote. “You have always been a role model for America’s youth, telling young people for years that they should never do drugs. We hope that you consider the harms of marijuana rescheduling and continue sending that strong message of hope to the next generation.” The House letter claims that the policy change is not needed in order to boost research, contrary to comments the president made earlier this week. Both the House and Senate letters—which were circulated as the White House confirmed to Marijuana Moment that Trump would be addressing cannabis rescheduling on Thursday—claim that the primary benefit of rescheduling would go to cannabis companies that would no longer subject to the federal tax penalty known as 280E and could write off their business expenses. .@RepAndyHarrisMD and I co-led a letter to President Trump, joined by 24 of our colleagues, urging him to oppose any effort to reschedule marijuana. Reclassifying marijuana would send the wrong message to our children, worsen addiction, undermine public safety, and hand… pic.twitter.com/nvSV4xyh6o — Pete Sessions (@PeteSessions) December 18, 2025 “This would incentivize addiction-for-profit dispensaries to advertise more kid-friendly products than ever,” the House lawmakers wrote. “Tax relief should be prioritized for hard-working, law-abiding Americans and businesses, not marijuana shops.” They also argue that enacting federal cannabis reform will make roads “more dangerous” due to impaired driving and will “hamper” Trump’s efforts to combat Chinese-linked criminal groups that operate illicit marijuana farms in the U.S. “These farms yield billions in revenue for Chinese traffickers and are an essential component of fentanyl money laundering schemes. According to the DEA, many of these Chinese marijuana farms are licensed by state governments. Thus, they will be eligible for the 280E-exempt tax deductions under Schedule III. Our country cannot adopt a policy that will provide tax relief to Chinese cartels that kill thousands of Americans every day.” “Schedule I drugs are addictive and have no medical value. Marijuana fits squarely into this category,” the House letter says. “Rescheduling tells our youth that marijuana use is acceptable and safe, a dangerous falsehood that will sink us deeper into our country’s drug crisis.” Growing the marijuana industry endangers the health and safety of Americans. The only winners from rescheduling will be bad actors like Communist China and drug traffickers. I led a letter with 22 of my Senate colleagues voicing concerns about marijuana rescheduling. pic.twitter.com/eVDSAd3zlX — Senator Ted Budd (@SenTedBuddNC) December 18, 2025 The senators’ letter, first reported by Punchbowl News, concluded by saying that “in light of the documented dangers of marijuana, facilitating the growth of the marijuana industry is at odds with growing our economy and encouraging healthy lifestyles for Americans.” “We urge you to continue your strong leadership of our country and our economy, and to turn away from marijuana rescheduling,” they said. The Senate letter was signed by 22 members, including Senate Majority Whip John Barrasso (R-WY), Republican Conference Chair Tom Cotton (R-AR) and Republican Policy Committee Chair Shelley Moore Capito (R-WV), along with Sens. Mitch McConnell (R-KY), Tommy Tuberville (R-AL), John Cornyn (R-TX), Ron Johnson (R-WI), Rick Scott (R-FL), Kevin Cramer (R-ND), Lindsey Graham (R-SC) and Cynthia Lummis (R-WY). In addition to Session and Harris, the House letter, first reported by Fox News, was also signed by 24 other lawmakers. Whether the messages from GOP lawmakers will influence the president’s decision remain to be seen, but numerous reports over the past week have affirmed that the rescheduling plan is in motion. That includes Marijuana Moment’s reporting on Wednesday that a White House official confirmed Trump is slated to address the issue on Thursday—while caveating that various rumors about the details are “speculation” until the administration finalizes a decision. As recently reported, the president’s executive order may also address ancillary issues related to CBD coverage through federal Medicare and a call for congressional action on cannabis banking. There are also rumors that a rescheduling decision will be coupled with presidential clemency, though the scope of that potential relief is unclear. That said, the White House spokesperson made clear that the deluge of details about the administration’s plans are speculative for now. But according to NBC News, the executive order may contain an explicit push from the president urging Congress to pass a bipartisan bill titled the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would prevent federal regulators for penalizing financial institutions simply for working with state-licensed marijuana businesses. The lack of banking access for the cannabis industry was also raised in a Senate subcommittee hearing on Tuesday. It’s also being speculated that the plan is to take a novel—albeit logistically complicated—approach to cannabidiol, a non-intoxicating component of the cannabis plant that’s widely used as a health supplement. Sources have said that drafts of the executive order have called on the Centers for Medicare and Medicaid Services (CMS) to amend its rules to let people on Medicare receive reimbursements for the cannabinoid product. That potential reform was also floated in a video from The Commonwealth Project touting the health benefits of CBD that Trump shared on Truth Social in late September. CMS implemented a rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services. But the agency has since revised the proposed rule, just weeks before the expected administrative order by Trump. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Read the marijuana letters to Trump below: The post GOP Lawmakers Urge Trump Not To Reschedule Marijuana In Last-Ditch Effort To Block Historic Reform appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Great Publish, I'm a large believer within publishing remarks upon websites in order to allow weblog authors realize that they’ve additional some thing beneficial in order to the internet! link slot

Virginia’s Senate president pro tempore has filed a bill to provide relief for people convicted of past cannabis crimes, mandating that individuals with certain offenses automatically receive resentencing hearings and have their punishments adjusted. The legislation is similar to proposals passed by lawmakers in recent sessions that were vetoed by Gov. Glenn Youngkin (R). The incumbent governor, however, will be leaving office next month and will be replaced by Gov.-elect Abigail Spanberger (D), who supports marijuana reform. The current proposal, filed on Monday by Sen. Louise Lucas (D), would create a process by which people who are incarcerated or on community supervision for certain felony offenses involving the possession, manufacture, selling or distribution of marijuana could receive an automatic hearing to consider modification of their sentences. The measure applies to people whose convictions are for conduct that occurred prior to July 1, 2021, when a state law legalizing personal possession and home cultivation of marijuana went into effect. “During his term, Governor Youngkin repeatedly rejected efforts to review and modify marijuana-related sentences,” JM Pedini, development director for the advocacy group NORML and executive director for Virginia NORML, told Marijuana Moment. “We’re ready to move this issue forward under the Spanberger administration and secure justice for those impacted.” The new sentencing relief bill comes as lawmakers are planning to pass legislation to legalize and regulate recreational marijuana sales to build on the state’s current noncommercial legalization law. Youngkin has also vetoed such proposals in the past, but Spanberger has pledged her support. “With all the excitement around a new market this is still one our most important bills that offers relief to the most harmed during Virginia’s full prohibition of marijuana,” Chelsea Higgs Wise, executive director of the advocacy group Marijuana Justice, told Marijuana Moment. “The resentencing bill is critical to show that Virginia is serious about providing repair along with building an equitable market,” she said. “Black Virginians were four times more likely to be arrested and convicted and there are still people serving sentences inside and on probation who deserve this relief while the commonwealth goes on to generate millions in revenue.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Sheba Williams, executive director of Nolef Turns said that “the time to address sentence modification for cannabis related offenses was at the moment that legalization became reality in Virginia.” “We had multiple opportunities to do what was right and necessary each year under the Youngkin administration but failed to address the most significant harm of prohibition—the people who have been impacted,” Williams, who is also a Virginia NORML board member and serves on the Virginia Cannabis Equity Reinvestment Board, said. “We hope that common sense and justice will apply to those impacted by the failed war on drugs as a new administration ushers in.” Earlier this month, the legislature’s Joint Commission to Oversee the Transition of the Commonwealth into a Cannabis Retail Market unveiled a much-anticipated proposal to legalize recreational marijuana sales that it is recommending lawmakers pass during the 2026 session. Lucas recently said the state should move forward with legalizing recreational marijuana sales—in part to offset the Trump administration’s cuts to federal spending in support of states. Separately, the Virginia Department of Labor and Industry published a new document this month outlining workplace protections for cannabis consumers. The post Top Virginia Senator Files Bill To Provide Sentencing Relief For People With Marijuana Convictions appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

I’m prompted while using the surpassing in addition to preachy checklist you give in such very little timing. Is John Spencer Ellis an expert in marketing?

In-app messages under the promo section list all active offers, while advertisements during major events embed codes. 1xbet promo code bd

A promotional code from 1 x bet will be presented to you to receive an increased 1xbet welcome bonus promo code. Using a bonus when allows you to get up to 100% on your first deposit and use it on bets on your favorite sporting events or a bonus offer on the first 5 deposits for gambling and also 1xbet promo code free spins. 1xbet free bet promo code

The 1xBet promo code: New888, represents more than a mere activation string—it's a strategic enhancer in the realm of digital wagering and gaming. 1xbet promo code today

A Republican senator has filed an amendment that would require the federal government to track the cost of hospitalization due to marijuana use. The proposal, from Sen. Ted Budd (R-NC), would require the secretary of the Department of Health and Human Services (HHS) to compile data on “Federal and State expenditures under the Medicaid program…that are attributable to costs incurred for providing medical assistance for inpatient hospital services, outpatient hospital services, and for services received at a hospital emergency room…related to marijuana use.” The information would be due in the form of a report to Congress within one year of the measure being enacted, along with any recommendations for legislation and administrative action that the HHS secretary determines to be appropriate. Legalization opponents have often claimed that cannabis drives an increase in hospital visits due to accidents and over-intoxication. Budd and other GOP senators sent a letter this week urging President Donald Trump not to follow through with plans to federally reschedule marijuana. The senator wants to attach the measure, which he filed on Tuesday, to spending legislation that would fund parts of the federal government for Fiscal Year 2026 that is currently awaiting Senate floor action. The full text of Budd’s marijuana amendment reads: “Sec. ____. The Secretary of Health and Human Services (in this section referred to as the ‘Secretary’) shall collect data relating to the amount of Federal and State expenditures under the Medicaid program established under title XIX of the Social Security Act (42 U.S.C. 1396 et seq.) that are attributable to costs incurred for providing medical assistance for inpatient hospital services, outpatient hospital services, and for services received at a hospital emergency room (without regard to whether such services are emergency services (as defined by the Secretary)) related to marijuana use (as defined by the Secretary). Not later than 1 year after the date of enactment of this division, the Secretary shall submit a report to Congress that includes such data and recommendations for such legislation and administrative action as the Secretary determines appropriate.” It’s not clear if the amendment will receive a vote on the Senate floor. The post GOP Senator Wants Feds To Study Hospital Costs Caused By Marijuana Use appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Use Visa or MasterCard for traditional banking, Skrill or Neteller for e-wallets, or cryptocurrencies like BTC and ETH with no upper limits. 1xbet today promo code

When you enter a 1xBet promo code for registration, you will automatically receive an increased bonus intended for newcomers. how to use 1xbet promo code

To activate this full package, simply use 1xBet casino promo code: New888 during registration to get up to €1950 + 150 free spins across your first four deposits. 1xbet promo code

“It’s not hyperbolic when I tell you that it saved her life. It definitely saved our marriage and our family.” By Jack Gorsline, Psychedelic State(s) of America On Tuesday, the Jackson, Michigan City Council passed a resolution to deprioritize the enforcement of laws against the purchase, cultivation and possession of certain psychedelic plants and fungi. The 4-2 vote in support of the municipal resolution was met with cheers from a large crowd of supporters who had gathered in the council chambers. The move makes Jackson the sixth municipality in the state of Michigan to approve such a measure—joining Ann Arbor, Detroit, Hazel Park, Ferndale, Ypsilanti and Washtenaw County in doing so. The resolution covers substances like ayahuasca, psilocybin and peyote—which are all currently prohibited at the state and federal levels. Notably, during the meeting, City Council Member Will Forgrave offered moving personal testimony, explaining that these entheogenic treatments succeeded where traditional methods failed in treating his wife’s postpartum depression. “It’s not hyperbolic when I tell you that it saved her life,” Forgrave said. “It definitely saved our marriage and our family. It’s something that’s near and dear to my heart.” In contrast, Council Members Arlene Robinson and Freddie Dancy voted against the measure, with Dancy attributing his “no” vote to his “personal convictions.” Beyond deprioritizing arrests, the resolution urges the Jackson County prosecutor to stop pursuing charges related to these plants. However, the policy maintains strict boundaries: the use or possession of entheogens remains prohibited for minors, on school property and while operating a vehicle. The Recipe for Success: Education and Persistence Alina DeRossett, Roger Maufort and Kate Brown, Co-Founders of Decriminalize Nature Jackson, credited the breakthrough vote to, “providing education, hard work and being diligent and consistent” in their outreach to city officials, “over three years.” Julie Barron—Founder of the Michigan Psychedelic Society told PSA that the measure’s passage serves as proof that, “even small, rural towns are willing to push the needle forward to help their community.” Barron also highlighted that, “the work of the local Decriminalize Jackson helped to convince enough council members to vote ‘yes.’” Can Local Momentum Spur Statewide Change? As for the status of statewide reform efforts, Barron told Lucid News earlier this year that an attempted 2024 statewide ballot initiative, “had some money committed to us” at first, but that ultimately long-term funding fell-through in part due to the high cost of effectively staffing such a lengthy campaign process, which she estimated as needing, “about a million dollars minimum.” At the Michigan state house in Lansing, earlier this year Rep. Mike McFall (D), introduced House Bill 4686, which if enacted into law would decriminalize possession of up to two ounces of psilocybin for adults with a medical record indicating post-traumatic stress disorder (PTSD). While the bill hasn’t garnered any further traction at the state house this session, the continued support from state lawmakers for some kind of policy advancement bodes well for future reform efforts. In her statement to Psychedelic State(s) of America, Barron acknowledged that while “Michigan has not yet had a successful statewide effort to decriminalize,” advocates across the Great Lakes State will, “continue to go city by city and county by county until we build the momentum for a successful statewide push.” On the national stage, Michigan native and co-founder of Decriminalize Nature Larry Norris heralded the local measure’s passage as further proof that the, “[psychedelics] movement transcends politics and can win in both progressive and conservative areas.” “At the end of the day people want to help support their community in healing…” Norris added, “and they realize the punitive approach to plants and mushrooms is not working.” The enthusiasm of local, state and national activists is certainly mirrored by local officials, too—as Jackson Mayor Daniel Mahoney publicly proclaimed after the successful vote, “I’m so happy we freed the [mu]shrooms!” This article was produced by Psychedelic State(s) of America – a nonprofit-sponsored news organization dedicated to rigorous independent psychedelic journalism. Subscribe to PSA online and Follow PSA on Instagram, LinkedIn, Twitter/X, Facebook. Learn more about PSA and donate to the PSA Media Fund here. The post Another Michigan City Passes Psychedelics Resolution Directing Police To Deprioritize Enforcement appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Thanks for sharing the post.. parents are worlds best person in each lives of individual..they need or must succeed to sustain needs of the family. togel online

The entire process takes less than two minutes, and 1xBet now includes a newbie progress guide in 2026 to prevent errors. Select sports or casino focus during signup, though support can assist changes later, ensuring you align the bonus with your preferred gaming style. 1xbet today promo code

GOP lawmaker slams rescheduling; Poll: Voters back legalization; Marijuana in public housing; ME gov candidate: don’t sign recriminalization petition Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Get our daily newsletter. Email address: Leave this field empty if you're human: Your support makes Marijuana Moment possible… Before you dig into today’s cannabis news, I wanted you to know you can keep this resource free and published daily by subscribing to Marijuana Moment on Patreon. We’re a small independent publication diving deep into the cannabis world and rely on readers like you to keep going. Join us at https://www.patreon.com/marijuanamoment / TOP THINGS TO KNOW A White House spokesperson confirmed to Marijuana Moment that President Donald Trump is “currently expected to address marijuana rescheduling” on Thursday, but added that “any details of this potential action until officially announced by the White House are speculation.” Sources familiar with the planning said a signing ceremony is scheduled for 1:30 PM ET and that the president will be surrounded by various cannabis industry and movement stakeholders when signing the order. President Donald Trump’s anticipated executive order on marijuana rescheduling could also contain provisions on cannabis industry banking access and Medicare coverage for CBD—and may additionally be accompanied by clemency actions—according to news reports and sources. Rep. Andy Harris (R-MD) is arguing that President Donald Trump “technically” can’t reschedule marijuana by executive order—though he acknowledged it “would be a heavy lift” to overturn the reform in Congress. A new poll commissioned by the conservative religious group Ethics and Public Policy Center shows that a majority of Americans support legalizing marijuana—though Trump voters are largely not on board, with the exception of younger ones. Sen. Cory Booker (D-NJ) and Rep. Eleanor Holmes Norton (D-DC) filed legislation to protect people who live in public housing from being evicted over marijuana use that is legal under state law. Maine Republican gubernatorial candidate David Jones said a proposed initiative to roll back marijuana legalization is “really dumb,” and he’s urging voters not to sign petitions to put it on the ballot. / FEDERAL The U.S. Tax Court upheld the Internal Revenue Service’s application of the 280E tax penalty to a marijuana business. The Drug Enforcement Administration is running a campaign it calls “30 Days of Drug Facts.” Sen. Catherine Cortez Masto (D-NV) tweeted, “Even if cannabis becomes a Schedule III drug, we need specific legislation like my SAFER Banking Act to allow legal cannabis businesses in Nevada to access banking services, accept debit and credit cards, and combat money laundering and fraud.” Former Rep. Matt Gaetz (R-FL) said it is “great to see” reports that President Donald Trump may issue a marijuana rescheduling order this week. The House bill to federally legalize marijuana got one new cosponsor for a total of 60. The House bill to create a pathway for patients to use Schedule I drugs got two new cosponsors for a total of 11. / STATES New Jersey Gov. Phil Murphy (D) commuted the parole supervision of a man who served time in prison for marijuana. A Missouri representative spoke about legislation to restrict hemp products. Colorado regulators issued an expanded health and safety advisory about cannabis products with pesticides above acceptable limits. The Michigan Court of Appeals ruled that a medical cannabis dispensary cannot deduct its business expenses from state taxes. New York regulators are being sued over new marijuana tracking rules. Maryland lawmakers will file legislation to decriminalize drug paraphernalia in the 2026 session. California regulators sent updates on various cannabis issues. Dozens of Alabama doctors have taken a course that’s required to be able to recommend medical cannabis. The Nevada Cannabis Compliance Board will meet on Thursday. — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — / SCIENCE & HEALTH A study found that “dietary cannabidiol supplementation enhances growth performance, meat quality and antioxidant capacity in Landes geese.” A study’s findings “support the idea that [medical marijuana] substitutes for prescription painkillers.” A study found that “chronic treatment with cannabidiol confers significant anti-seizure benefit to the mouse model of [late infantile neuronal ceroid lipofuscinosis] disease.” / ADVOCACY, OPINION & ANALYSIS The Washington Post editorial board is calling for federal marijuana legalization. Prohibitionist organization Smart Approaches to Marijuana launched a new ad urging President Donald Trump not to reschedule cannabis. CNN commentator Harry Enten said President Donald Trump rescheduling marijuana “would be some of his best politics in a long time.” / BUSINESS Vireo Growth Inc. is acquiring certain Colorado assets from PharmaCann Inc. Trulieve Cannabis Corp. closed a private placement of senior secured notes for aggregate gross proceeds of $140 million. Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox. Get our daily newsletter. Email address: Leave this field empty if you're human: Photo courtesy of Chris Wallis // Side Pocket Images. The post Trump cannabis order could touch banking & CBD Medicare coverage (Newsletter: December 18, 2025) appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Helpful — I valued the transparency on player complaint resolution timelines. Quick, fair resolution processes prevent toxic situations from escalating. Real votes showed which teams are responsive. slot gacor Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. Neurologische Praxis München Excellent list — the server comparison tools simplified my decision. Side-by-side stats like drop rates and population were priceless. Real votes added the final confirmation. sociéte de recouvrement paris I had most recently initiated a fabulous web page, the details you will provide you with here comes with really helped others really. Regards just for all of the effort & succeed. Multi-Shot AI Video Generator Frequent goes to here i will discuss the obvious way to appreciate it on your attempt, which often is why Now i am viewing the internet site day-to-day, in search of completely new, useful facts. Quite a few, many thanks! hbowin Excellent roundup — I appreciated the filter for low-population but active servers. Smaller communities often offer friendlier vibes and cooperation. Real player rankings showed which small servers thrive. sociéte de recouvrement marseille

Seeking an unforgettable interlude in the heart of the capital? Your chosen Russian Surat call girls is prepared to offer exceptional companionship, designed to captivate and enchant. Revel in sophisticated conversation and a charming presence, ensuring your time together is uniquely personal and incredibly satisfying, every single time.

A White House spokesperson has confirmed to Marijuana Moment that President Donald Trump is “currently expected to address marijuana rescheduling” on Thursday, though they added that “any details of this potential action until officially announced by the White House are speculation.” This comes amid a rapidly churning rumor mill about the president’s potential plans to issue an executive order directing the attorney general to proceed with a proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA). Sources familiar with the administration’s planning tell Marijuana Moment that an announcement on the rescheduling move is planned for 1:30pm ET and that Trump will be surrounded by various cannabis industry and movement stakeholders when signing the order. As recently reported, the president’s executive order may also address ancillary issues related to CBD coverage through federal Medicare and a call for congressional action on cannabis banking. There are also rumors that a rescheduling decision will be coupled with presidential clemency, though the scope of that potential relief is unclear. That said, the White House spokesperson made clear that the deluge of details about the administration’s plans are speculative for now. But according to NBC News, the executive order may contain an explicit push from the president urging Congress to pass a bipartisan bill titled the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would prevent federal regulators for penalizing financial institutions simply for working with state-licensed marijuana businesses. The lack of banking access for the cannabis industry was also raised in a Senate subcommittee hearing on Tuesday. It’s also being speculated that the plan is to take a novel—albeit logistically complicated—approach to cannabidiol, a non-intoxicating component of the cannabis plant that’s widely used as a health supplement. Sources have said that drafts of the executive order have called on the Centers for Medicare and Medicaid Services (CMS) to amend its rules to let people on Medicare receive reimbursements for the cannabinoid product. That potential reform was also floated in a video from The Commonwealth Project touting the health benefits of CBD that Trump shared on Truth Social in late September. CMS implemented a rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services. But the agency has since revised the proposed rule, just weeks before the expected administrative order by Trump. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. The post White House Confirms Trump Will ‘Address Marijuana Rescheduling’ Thursday, But Reported Details On Final Decision Are ‘Speculation’ appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

As President Donald Trump prepares to announce a decision on marijuana rescheduling, a new poll from a religious conservative research firm again shows that a majority of Americans are ready for legalizing cannabis altogether. Trump voters, however, are largely not on board with the change—with the exception of younger ones. The survey—conducted by YouGov on behalf of the Ethics and Public Policy Center (EPPC)—was detailed in a post published by one of the organization’s lead researchers on his Family Matters blog last week. Overall, it found that 57 percent of respondents either “somewhat” or “strongly” support cannabis legalization. A demographic breakdown of age and political affiliation showed some familiar divides on the issue, with a majority of people aged 46 and older who voted for Trump in the last election (53 percent) oppose legalization. However, a 49 percent plurality of Trump voters 18-45 said they do back the reform. Among people who voted for former Vice President Kamala Harris in the last election, however, there was a somewhat unusual finding: More people in the older cohort (87 percent) said they support legalization than those in the younger cohort (71 percent). A majority of Republicans oppose marijuana legalization, with even young GOP voters are pretty split, and those with kids really don't like it. Rescheduling pot will make young men worse off — and it won't save the GOP in next year's midterms, either: https://t.co/gQR3o3S0rF https://t.co/scEFw0PdQc pic.twitter.com/ubWbgQr7X0 — Patrick T. Brown (@PTBwrites) December 12, 2025 Asked about the net effect of legalization on society, 68 percent of younger Harris voters said it leads to “more social benefits than costs,” and an even larger majority (82 percent) of older Harris voters said the same. By contrast, a majority of both younger and older Trump voters (59 percent and 67 percent, respectively) said legalization is associated with “more social costs than benefits.” Adults 18-45 without children were more supportive of ending prohibition at 60 percent, compared to 52 percent who are parents, the poll found. “This offers a sketch for what a new political coalition interested in curbing the excesses of our rapid entry into a world of widespread medical marijuana might look like,” EPPC’s Patrick Brown said, adding that if the Trump administration does move to reschedule marijuana, “conservatives and well-meaning liberals shouldn’t accept a new reality of capitalism-fueled marijuana availability without a fight.” “The concerns about what widespread weed could mean for children’s health—and young adults’ long-term outcomes—won’t have gone away, regardless of the profit motives involved,” he said. While this poll does show a partisan split on the issue with most Republicans against legalization, other independent surveys over recent years have signaled that ending prohibition is an increasingly bipartisan issue. That said, support among GOP voters dipped somewhat over the last year, according to a recent Gallup poll. A separate research firm associated with Trump survey of registered voters did recently show that a majority of Republicans back a variety of cannabis reforms, including rescheduling, states’ rights to legalize and marijuana industry access to banking services and stock exchanges. Sources familiar with the administration’s potentially imminent decision on marijuana reform haven’t been suggesting that the president intends to legalize marijuana, however. The proposal to move cannabis from Schedule I to Schedule III of the Controlled Substances Act (CSA) would mean it’d still be federally prohibited. But marijuana businesses could then start taking federal tax deductions, and it could help reduce certain research barriers associated with Schedule I drugs. There was also reporting this week indicating that the executive order on rescheduling that the president is expected to issue may also contain additional components touching on cannabis business banking access and Medicare coverage for CBD. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — or what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Mike Latimer. The post Most Americans Back Legalizing Marijuana, But Trump Voters Not On Board, Conservative Group’s Poll Shows Amid Rescheduling Rumors appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Sen. Cory Booker (D-NJ) and Rep. Eleanor Holmes Norton (D-DC) have filed a bill in Congress to allow people living in federally assisted housing to use marijuana in compliance with state laws without having to fear losing their homes. Under current policy, people who live in public housing are prohibited from using controlled substances in those facilities regardless of state law, and landlords are able to evict them. The new bicameral legislation—titled the “Marijuana in Federally Assisted Housing Parity Act”—would change that. The bill would provide protections for people living in public housing or Section 8 housing from being displaced simply for using cannabis in states that have legalized it for medical or recreational purposes. Norton has filed similar versions of the proposal over recent sessions, but the reform has yet to be enacted. Booker joined Norton in sponsoring the legislation last Congress as well. “Tenants should not be discriminated against, evicted, or denied federally assisted housing for legally using marijuana or treating a medical condition in states where it is permitted,” Booker said in a press release on Wednesday. “The Marijuana in Federally Assisted Housing Parity Act would end these discriminatory practices and ensure tenants are not punished for personal choices made in accordance with state law.” The bill would further require the head of the U.S. Department of Housing and Urban Development (HUD) to enact regulations that restrict smoking marijuana at these properties in the same way that tobacco is handled. “Individuals living in federally funded housing should not fear eviction simply for treating their medical conditions or for seeking a substance legal in their state,” Norton said. “Increasingly, Americans are changing their views on marijuana, and it is time that Congress caught up with its own constituents. With so many states improving their laws, this issue should have broad bipartisan appeal because it protects states’ rights.” Marijuana is legal in 40 states, yet people in federally funded housing can still be evicted for using it. I introduced a bill with @SenBooker to fix this and align federal law with the 90% of Americans who support legal medical marijuana. pic.twitter.com/tR0ZjTyXYT — Eleanor #DCStatehood Holmes Norton (@EleanorNorton) December 17, 2025 In 2018, a Trump administration official said that she was working to resolve conflicting federal and state marijuana laws as it applies to residency in federally-subsidized housing, but it’s not clear what came of that effort. Norton sent a letter to HUD in 2021 that implored the department to use executive discretion and not punish people over cannabis in legal states. In response, the President Joe Biden’s HUD secretary told the congresswoman that it is statutorily required to continue denying federally assisted housing to people who use marijuana, even if they’re acting in compliance with state law. Booker and Rep. Maxwell Alejandro Frost (D-FL) filed a bill last year to repeal a decades-old federal statute that’s led to the denial of housing for millions of people with prior drug convictions. — Marijuana Moment is tracking more than 1,000 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — Rep. Alexandria Ocasio-Cortez (D-NY) also raised the issue during a committee hearing in 2019, pressing former HUD Secretary Ben Carson on policies that cause public housing residents and their families to be evicted for committing low-level offenses such as marijuana possession. Ocasio-Cortez and then-Sen. Kamala Harris (D-CA) also filed legislation that year that would protect people with low-level drug convictions from being denied access to or being evicted from public housing. Sen. Jeff Merkley (D-OR) also introduced an affordable housing bill in 2020 that included a provision to prevent landlords from evicting people over manufacturing marijuana extracts if they have a license to do so. The post New Congressional Bill Would Let People Use Marijuana In Public Housing Without Being Evicted appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order directing federal agencies to complete the marijuana rescheduling process. But multiple reports indicate that the directive could also contain additional components touching on cannabis business banking access and Medicare coverage for CBD. The exact details of the executive order aren’t clear, but White House sources seem to be coalescing around the idea that it will be signed on Thursday and will instruct the Justice Department to proceed with plans to move marijuana from Schedule I to Schedule III of the Controlled Substances Act (CSA). A source familiar with fluid discussions around the administrative action also told Marijuana Moment that Trump may couple the presidential directive with clemency for some people who have been convicted over federal marijuana offenses. Neither that plan, nor the reported details about cannabis banking or CBD and health care, have yet been confirmed, however. According to NBC News, the potentially imminent executive order may contain an explicit push from the president urging Congress to pass a bipartisan bill titled the Secure and Fair Enforcement Regulation (SAFER) Banking Act, which would prevent federal regulators for penalizing financial institutions simply for working with state-licensed marijuana businesses. The lack of banking access for the cannabis industry was also raised in a Senate subcommittee hearing on Tuesday. It’s also being speculated that the plan is to take a novel—albeit logistically complicated—approach to cannabinol, a non-intoxicating component of the cannabis plant that’s widely used as a health supplement. Sources have said that drafts of the executive order have called on the Centers for Medicare and Medicaid Services (CMS) to amend its rules to let people on Medicare receive reimbursements for the cannabinoid product. That potential reform was also floated in a video from The Commonwealth Project touting the health benefits of CBD that Trump shared on Truth Social in late September. CMS implemented a rule in April specifically stipulating that marijuana, as well as CBD that can be derived from federally legal hemp, are ineligible for coverage under its Medicare Advantage program and other services. But the agency has since revised the proposed rule, just weeks before the expected administrative order by Trump. Marijuana Moment reached out to the White House for clarification on the rumored executive order, but a spokesperson did not respond by the time of publication. On Monday, Trump said he is “very strongly” considering rescheduling cannabis in part to ease restrictions on research into its effects. Opponents of the policy change have stepped up their efforts to dissuade the administration from moving forward, arguing that a reclassification to Schedule III will further normalize marijuana use even though it would not federally legalize the plant. Rescheduling would, however, let marijuana businesses take federal tax deductions while reducing certain research barriers associated with Schedule I drugs. Rep. Andy Harris (R-MD), one of the more vocal prohibitionists in Congress, said this week that Trump doesn’t have the authority to unilaterally reschedule marijuana via executive order. But while lawmakers could overrule any administrative move to enact the reform, it would be a “heavy lift” in the Republican-controlled Congress, he acknowledged. Meanwhile, multiple top congressional Democrats are making the case that the modest reform would not go far enough—including Sen. Ron Wyden (R-OR) who said the move is only an attempt by the president to “gaslight” voters into thinking he legalized cannabis to boost his “pathetic” approval ratings. A major drug testing industry organization separately said it’s “sounding the alarm” amid the reports Trump may soon finalize the rescheduling proposal, arguing that the policy change would “have catastrophic consequences for the safety of the United States workforce and transportation sectors.” — Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments. Learn more about our marijuana bill tracker and become a supporter on Patreon to get access. — For what it’s worth, a White House spokesperson told Marijuana Moment last week that no actions have been finalized so far. Bipartisan congressional lawmakers have been weighing in on the potential rescheduling decision over the past week—with Democrats like Rep. Alex Ocasio-Cortez (D-NY) calling the reform a “no-brainer” and others like Rep. Andy Harris (R-MD) pushing back against the proposal. The Washington Post reported last week that Trump was planning to issue an executive order directing federal agencies to move ahead with cannabis rescheduling. The outlet also said the president met earlier this week in the Oval Office with marijuana industry executives, Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare and Medicaid Services Administrator Mehmet Oz. During that meeting, Trump phoned Johnson, the House speaker, who expressed his opposition to rescheduling cannabis, If the administration does ultimately enact rescheduling, it would mark one of the most significant developments in federal marijuana policy since its prohibition a half a century ago, with a Schedule III reclassification recognizing that marijuana has medical value and a lower abuse potential compared to other Schedule I drugs like heroin. Photo courtesy of Philip Steffan. The post Trump’s Marijuana Rescheduling Order Could Include Industry Banking And CBD Medicare Coverage Provisions, Sources Say appeared first on Marijuana Moment. View the live link on MarijuanaMoment.net